US equities
|
SPCX
$144.75
▼-9.14%
MU
$856.49
▼-6.26%
NVDA
$212.21
▼-4.40%
META
$648.85
▼-6.98%
TSLA
$374.58
▼-3.08%
AAPL
$348.22
▲+1.23%
AMD
$507.93
▼-8.10%
SNDK
$1,260.93
▼-8.51%
SPCX
$144.75
▼-9.14%
MU
$856.49
▼-6.26%
NVDA
$212.21
▼-4.40%
META
$648.85
▼-6.98%
TSLA
$374.58
▼-3.08%
AAPL
$348.22
▲+1.23%
AMD
$507.93
▼-8.10%
SNDK
$1,260.93
▼-8.51%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Rich Stoner
Recent news which mentions Rich Stoner
Cheaper, more accessible cell, gene therapies? Nobel winner's task force points the way
July 25, 2023
Tags
Rich Stoner
Pharmaceuticals
Biotech
From
Business Journals